Press Releases Detail

Global Predictive Biomarkers Market

According to the Foreclaro Global Research, the Global Predictive Biomarkers Market size was valued at USD 23854.5 million in 2024. The report “Global Predictive Biomarkers Market Segmentation, By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Lipid Biomarkers, Immune Biomarkers), By Application (Oncology, Cardiology, Neurology, Infectious Diseases, Autoimmune Disorders, Endocrinology, Gastroenterology), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunoassays, Mass Spectrometry, Microarray Technology, Bioinformatics and Artificial Intelligence) By End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Academic & Research Institutions, Hospitals & Clinics, Contract Research Organizations (CROs))- Industry Trends and Forecast to 2033” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Global Predictive Biomarkers Market is expanding rapidly because of the growing need for personalized medicine alongside chronic diseases becoming more common and the progress made in molecular diagnostics. Predictive biomarkers function as essential tools for selecting patients who will respond successfully to specific treatments which leads to improved targeted treatment strategies. The medical fields of oncology, cardiology, and neurology showcase this trend through their increasing adoption of precision treatment methods. The market demonstrates potential growth yet struggles with high development expenses, complicated validation stages, and regulatory barriers. Emerging markets present powerful opportunities because healthcare infrastructure expansion and increasing investments in genomics and diagnostic technologies create favorable conditions. Advanced technologies such as AI, bioinformatics, and next-generation sequencing, combined with predictive biomarkers, will speed up drug development and diagnostic precision, which will improve patient health results and support the transformation of worldwide healthcare infrastructures.

Have any questions or need more information? Click the link below to request a sample or make an inquiry before making your purchase:

https://foreclaroglobalresearch.com/research-report/global-predictive-biomarkers-market

 

Global Predictive Biomarkers Market Report Highlights

• The predictive biomarkers market is dominated by the oncology segment because precision therapies for cancer treatment require high demand. Targeted therapy decisions and improved patient outcomes rely heavily on biomarkers which establish their indispensable role in current oncology treatment practices.
• Genetic biomarkers represent the biggest market share because they serve essential roles in predicting disease risk and selecting therapies, mainly in cancer and genetic disorders.
• The widespread adoption of Next-Generation Sequencing (NGS) stems from its capability to accurately analyze numerous biomarkers at once, which enables quicker and more economical diagnostic processes.
• Market-leading organizations depend on predictive biomarkers to advance their drug development processes and clinical trial methodologies while creating targeted therapeutic innovations.
• The region is expected to experience the highest CAGR, driven by enhanced investments in genomics alongside improved healthcare access and escalating chronic disease rates within China, India, and South Korea.
• Thermo Fisher Scientific, Roche, Qiagen, and Illumina are accelerating market consolidation by establishing partnerships and pursuing acquisitions to enhance biomarker research and global market presence.

Foreclaro Global Research has segmented the Predictive Biomarkers Market report based on Biomarker Type, Application, Technology, End User and region:

 

Predictive Biomarkers Market, Biomarkers Type Outlook (Revenue - USD Million, 2020 - 2033)

Genetic Biomarkers

Protein Biomarkers

Metabolic Biomarkers

Epigenetic Biomarkers

Transcriptomic Biomarkers

Lipid Biomarkers

Immune Biomarkers

 

Predictive Biomarkers Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Oncology

Cardiology

Neurology

Infectious Diseases

Autoimmune Disorders

Endocrinology

Gastroenterology

 

Predictive Biomarkers Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)

Polymerase Chain Reaction (PCR)

Next-Generation Sequencing (NGS)

Immunoassays

Mass Spectrometry

Microarray Technology

Bioinformatics and Artificial Intelligence

 

Predictive Biomarkers Market, End Users Outlook (Revenue - USD Million, 2020 - 2033)

Pharmaceutical & Biotechnology Companies

Diagnostic Laboratories

Academic & Research Institutions

Hospitals & Clinics

Contract Research Organizations (CROs)

 

Predictive Biomarkers Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

United States

Canada

Mexico

 

Europe

United Kingdom

Germany

France

Spain

Italy

Rest of Europe

 

Asia Pacific

China

India

Japan

Australia

South Korea

Rest of Asia Pacific

 

Latin America

Brazil

Argentina

Rest of Latin America

 

Middle East & Africa

Saudi Arabia

South Africa

Rest of MEA

 

Global Predictive Biomarkers Market Key Players:

Thermo Fisher Scientific

F. Hoffmann‑La Roche (Roche)

Qiagen

Illumina

Bio‑Rad Laboratories

Danaher Corporation

Siemens Healthineers

Myriad Genetics

PerkinElmer

Becton Dickinson (BD)

Bio‑Techne

Genomic Health

Epigenomics AG

Ayoxxa Biosystems

Quibim